Skip to content
AwardedLithuaniaGoods€0

Monokloniniai antikūnai metastazavusiam gaubtinės arba tiesiosios žarnos vėžiui gydyti (Cetuximab) ir (ar) (Panitumumab)

Published
Published 15 October 2025
Deadline
Closed 19 November 2025

Overview

Perkančioji organizacija numato įsigyti – monokloninius antikūnus metastazavusiam gaubtinės arba tiesiosios žarnos vėžiui gydyti (Cetuximab ir/arba Panitumumab). Reikalavimai pirkimo objektui ir perkami vaistų kiekiai nustatyti SS 2 priede „Techninė specifikacija“.

Key details

Country
Lithuania
Status
Awarded
Category
Goods
Estimated value
€0
Procedure
Open
Published
15 October 2025
Deadline
Closed
Classification (CPV)
Antineoplastic agents

Award outcome

Awarded value
€1,319,749
Award date
12 January 2026
Contract period
— → 7 January 2027
Winner
  • UAB Liukrena

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    21 January 2026

  2. Contract Notice

    15 October 2025

Contracting authority

  • Valstybinė ligonių kasa prie Sveikatos apsaugos ministerijos

    Procuring entity

    Vilnius, Lithuania

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Monokloniniai antikūnai metastazavusiam gaubtinės arba tiesiosios žarnos vėžiui gydyti (Cetuximab) ir (ar) (Panitumumab) — won by UAB Liukrena — Skim